FDA Inspection 1249346 — Takeda Manufacturing Austria AG
The FDA completed an inspection of Takeda Manufacturing Austria AG on Apr 24, 2024 in Orth An Der Donau. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 24, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Orth An Der Donau (Austria)
Additional Details
Mutual Recognition Agreement (MRA)